Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
Top Cited Papers
- 1 January 2013
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 58 (1), 58-64
- https://doi.org/10.1016/j.jhep.2012.08.017
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratioThe American Journal of Surgery, 2010
- Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver TransplantationTransplantation, 2009
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisThe Lancet Oncology, 2008
- Preoperative Neutrophil‐to‐Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular CarcinomaWorld Journal of Surgery, 2008
- Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinomaJournal of Surgical Oncology, 2008
- Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancerJournal of Surgical Oncology, 2005
- Inflammation and cancerNature, 2002
- Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survivalHepatology, 2001
- Inflammation and cancer: back to Virchow?The Lancet, 2001
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisThe New England Journal of Medicine, 1996